Home » Topics » Disease categories and therapies » Gastrointestinal

Gastrointestinal
RSS

Shaman commences phase II trials of Provir in AIDS-related diarrhea

April 1, 1997

Kaken prepares broad-spectrum antiulcer agent

March 27, 1997

Axcan receives approvable letter for URSO from FDA

March 26, 1997

Synsorb Cd enters phase II

March 26, 1997

Daiichi Pharmaceutical presents novel antisecretory agent

March 25, 1997

Byk Canada begins operations

March 21, 1997

Gastric prokinetic agent developed by Kyorin

March 19, 1997

Fujisawa prepares PLA2 inhibitors

March 19, 1997

Combination therapy for idiopathic intractable hiccup

March 18, 1997

Oral and intravenous pharmacokinetics of SDZ-HTF-919 in humans

March 18, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 9, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 9, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Development and characterization of anti-CD19 in vivo CAR T therapy
BioWorld Science
Shenzhen Grit Biotechnology Co. Ltd. and Shanghai Vitalgen Biopharma Co. Ltd. recently presented their work to develop and evaluate a novel anti-CD19 in vivo CAR...
Preclinical results of anti-ADAMTS13 antibody in acquired von Willebrand syndrome
BioWorld Science
The acquired von Willebrand syndrome (AVWS) is a rare bleeding disorder with laboratory findings similar to those of inherited von Willebrand disease. Researchers...